The mechanism underlying the anti-tumor effects of apigenin in hepatocellular carcinoma HepG2 cells is related to the induction of apoptosis and autophagy through the inhibition of the PI3K/AKT/mTOR pathway [113]. Here, AKT1 is linked to neoplasm.